With its purely refractive design, the TECNIS PureSee IOL ensures surgeons’ ease of use in providing high tolerance to ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...

Dezeen School Shows: we've rounded up seven student projects featured in Dezeen School Shows that utilise modern technology ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...

Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that ...

Contributor content. As a health care IT specialist, Vedamurthy Yogeshappa uses Artificial Intelligence (AI) to streamline ...

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Dr. Diamond’s Metacine adds a third and final product to the InstaFacial Collection, making its results even more impressive.